Streamlining Biotherapy QC: Practical Solutions For Protein Analytics And Residual DNA Testing

Ensuring the purity, safety, and consistency of biologic therapies under strict regulatory scrutiny requires precise and reliable analytical methods. This is particularly true for two critical areas: HPLC protein analytics and residual DNA testing, where technical bottlenecks often delay production timelines.

Tune in to this presentation to learn strategies for overcoming the most common QC challenges encountered during biotherapy manufacturing. You'll explore strategies to improve the robustness and reproducibility of your protein analytics and DNA testing workflows, moving from reactive troubleshooting to proactive QC planning. Discover how strengthening your QC strategies can reduce compliance risks and help accelerate your path to market. Watch the on-demand webinar now to learn more.